Abstract
The function of the human heart is characterised by complex patterns of motion that change throughout our lifespan due to accumulated damage across biological scales. Understanding the drivers of cardiac ageing is key to developing strategies for attenuating age-related processes. The motion of the surface of the heart can be conceived as a graph of connected points in space moving through time. Here we develop a generalisable framework for modelling three-dimensional motion as a graph and apply it to a task of predicting biological age. Using sequences of segmented cardiac imaging from 5064 participants in UK Biobank we train a graph neural network (GNN) to learn motion traits that predict healthy ageing. The GNN outperformed (mean absolute error, MAE = 4.74 years) a comparator dense neural network and boosting methods (MAE = 4.90 years and 5.08 years, respectively). We produce human-intelligible explanations of the predictions and using the trained model we also assess the effect of hypertension on biological age. This work shows how graph representations of complex motion can efficiently predict biologically meaningful outcomes.
Competing Interest Statement
Declan P O'Regan has received research support and consultancy fees from Bayer AG.
Funding Statement
The study was supported by Medical Research Council (MC\_UP\_1605/13); National Institute for Health Research (NIHR) Imperial College Biomedical Research Centre; and the British Heart Foundation (RG/19/6/34387, RE/18/4/34215).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participants provided written informed consent for participation in the study, which was approved by the National Research Ethics Service (11/NW/0382) in the UK.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵† Joint first authors.
Data Availability
All raw and derived data in this study are available from UK Biobank (http://www.ukbiobank.ac.uk/).
